 |
|
Diagnostic Validity of the Dementia Questionnaire for Alzheimer Disease
Ronald J. Ellis, MD, PhD;
Kaining Jan, MD;
Claudia Kawas, MD;
William C. Koller, MD;
Kelly E. Lyons, PhD;
Dilip V. Jeste, MD;
Larry A. Hansen, MD;
Leon J. Thal, MD
Arch Neurol. 1998;55:360-365.
Objective To determine the sensitivity and specificity of postmortem dementia diagnoses based on a retrospective informant interview by comparison with criterion standard neuropathological diagnoses and the results of previous clinical examinations.
Setting Three university-based academic research centers.
Subjects Fifty-four deceased elderly persons with Alzheimer disease, another dementing disorder, a neurologic disease resulting in functional impairment but no dementia, or no neurologic disorder.
Methods Blinded nonclinician interviewers administered the Dementia Questionnaire (DQ) by telephone to informants, typically close relatives, who were familiar with the intellectual and functional status of the subjects before death. Two senior clinicians (L.J.T. and C.K.) rated each DQ for the presence or absence of a dementia syndrome during life and for the specific disorders causing the dementia, if present. Raters were blinded to the neuropathological findings and based their assessments only on data provided by responses to the DQ. Comparison was made with diagnoses based on neuropathological assessment. In most cases, the results of antemortem clinical examinations were also available as a check on the clinical diagnosis of the dementia syndrome. Sensitivity and specificity of the DQ diagnoses were computed, and chance-corrected agreement measures were calculated for the 2 independent DQ raters (L.J.T. and C.K.).
Results Compared with antemortem clinical diagnosis, the average sensitivity of the DQ for the clinical syndrome of dementia was 92.8%, the specificity was 89.5%, and the interrater agreement was 98% ( =0.96). Among 7 subjects with mild dementia (Mini-Mental State Examination score  24 at the last clinical examination), 5 (71%) were correctly identified using the DQ. The DQ correctly indicated the absence of dementia in 8 (80%) of 10 subjects with other neurologic disorders causing functional impairment. Compared with the neuropathological diagnoses, the DQ differentiated Alzheimer disease from other primary causes of dementia with a sensitivity of 89% and a specificity of 72%. The interrater agreement was 93.8% (=0.85).
Conclusions Compared with the results of the antemortem clinical examinations, the DQ was sensitive to the presence of dementia, detected most cases of mild dementia, and discriminated dementia from other neurologic disorders causing functional impairment. Compared with the neuropathological diagnoses, the ability of the DQ to differentiate Alzheimer disease from other dementing disorders indicates that it may be useful as a research tool.
From the Departments of Neurosciences (Drs Ellis, Hansen, and Thal) and Psychiatry (Dr Jeste), University of California, San Diego; the San Diego Veterans Affairs Medical Center (Drs Ellis, Jeste, and Thal); Department of Medicine, the Cedars-Sinai Medical Center, Los Angeles, Calif (Dr Jan); Department of Neurology, The Johns Hopkins University, Baltimore, Md (Dr Kawas); and the Department of Neurology, University of Kansas, Kansas City (Drs Koller and Lyons).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
A review of screening tests for cognitive impairment
Cullen et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:790-799.
ABSTRACT
| FULL TEXT
Variability of Familial Risk of Alzheimer Disease Across the Late Life Span
Silverman et al.
Arch Gen Psychiatry 2005;62:565-573.
ABSTRACT
| FULL TEXT
Relationship Between Body Height and Dementia
Schnaider Beeri et al.
AJGP 2005;13:116-123.
ABSTRACT
| FULL TEXT
Diabetes mellitus in midlife and the risk of dementia three decades later
Schnaider Beeri et al.
Neurology 2004;63:1902-1907.
ABSTRACT
| FULL TEXT
APOE and AD concordance in twin pairs as predictors of AD in first-degree relatives
Steffens et al.
Neurology 2000;54:593-593.
ABSTRACT
| FULL TEXT
|
